Both in Pharmaceuticals
MoonLake Immunotherapeutics vs Savara
Over the past year MLTX returned +15.5% and SVRA returned +12.9%; their daily moves had a correlation of 0.27.
MLTX +15.5% SVRA +12.9%Growth of $1, one year, split-adjusted
| Metric | MLTX | SVRA |
|---|---|---|
| Price | $11.78 | $4.82 |
| Market cap | $1.00B | $990.3M |
| Today | −6.28% | −2.63% |
| 1 month | +2.7% | −4.5% |
| 6 months | −29.6% | −5.9% |
| Year to date | −10.6% | −20.1% |
| 1 year | +22.6% | +11.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $437.5M | $142.9M |
| Dividend yield | — | — |
| Volatility (60d) | 58.0% | 48.5% |
| Short % of float | 14.3% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).